Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2024-01-23 Sale |
2024-01-23 8:37 pm |
Mirati Therapeutics Inc. | MRTX | Christensen Jamie EVP & Chief Scientific Officer |
154,996 | $0 | $0 | 0 (Direct) |
View |
2024-01-16 Sale |
2024-01-18 4:38 pm |
Mirati Therapeutics Inc. | MRTX | Christensen Jamie EVP & Chief Scientific Officer |
1,597 | $59.02 | $94,255 | 155,927 (Direct) |
View |
2024-01-04 Sale |
2024-01-05 5:34 pm |
Mirati Therapeutics Inc. | MRTX | Christensen Jamie EVP & Chief Scientific Officer |
1,531 | $58.81 | $90,038 | 157,135 (Direct) |
View |
2023-12-18 Sale |
2023-12-19 4:59 pm |
Mirati Therapeutics Inc. | MRTX | Christensen Jamie EVP & Chief Scientific Officer |
2,387 | $57.5 | $137,253 | 141,645 (Direct) |
View |
2023-09-08 Sale |
2023-09-12 5:41 pm |
Mirati Therapeutics Inc. | MRTX | Christensen Jamie EVP & Chief Scientific Officer |
2,388 | $35.63 | $85,084 | 144,032 (Direct) |
View |
2023-05-24 Sale |
2023-05-24 7:38 pm |
Mirati Therapeutics Inc. | MRTX | Christensen Jamie EVP & Chief Scientific Officer |
619 | $45.29 | $28,035 | 124,123 (Direct) |
View |
2023-01-17 Sale |
2023-01-19 09:45 am |
Mirati Therapeutics Inc. | MRTX | Christensen Jamie EVP, Chief Scientific Officer |
2,245 | $42.38 | $95,142 | 97,878 (Direct) |
View |
2023-01-04 Sale |
2023-01-05 5:13 pm |
Mirati Therapeutics Inc. | MRTX | Christensen Jamie EVP, Chief Scientific Officer |
1,949 | $46.6 | $90,823 | 100,123 (Direct) |
View |
2022-12-16 Sale |
2022-12-20 4:02 pm |
Mirati Therapeutics Inc. | MRTX | Christensen Jamie EVP, Chief Scientific Officer |
2,410 | $43 | $103,624 | 102,072 (Direct) |
View |
2022-12-02 Sale |
2022-12-05 5:00 pm |
Mirati Therapeutics Inc. | MRTX | Christensen Jamie EVP, Chief Scientific Officer |
1,726 | $90.19 | $155,667 | 104,482 (Direct) |
View |
2022-05-23 Sale |
2022-06-14 4:35 pm |
Mirati Therapeutics Inc. | MRTX | Christensen Jamie EVP, Chief Scientific Officer |
624 | $63.54 | $39,649 | 86,804 (Direct) |
View |
2022-01-18 Sale |
2022-01-18 8:33 pm |
Mirati Therapeutics Inc. | MRTX | Christensen Jamie EVP, Chief Scientific Officer |
627 | $120.51 | $75,558 | 105,249 (Direct) |
View |
2022-01-04 Sale |
2022-01-06 4:51 pm |
Mirati Therapeutics Inc. | MRTX | Christensen Jamie EVP, Chief Scientific Officer |
1,442 | $147.72 | $213,017 | 77,300 (Direct) |
View |
2021-12-06 Sale |
2021-12-07 5:52 pm |
Mirati Therapeutics Inc. | MRTX | Christensen Jamie EVP, Chief Scientific Officer |
1,201 | $130.79 | $157,078 | 59,505 (Direct) |
View |
2021-05-24 Sale |
2021-05-25 6:04 pm |
Mirati Therapeutics Inc. | MRTX | Christensen Jamie EVP, Chief Scientific Officer |
435 | $154.34 | $67,138 | 53,850 (Direct) |
View |
2021-01-06 Sale |
2021-01-08 7:15 pm |
Mirati Therapeutics Inc. | MRTX | Christensen Jamie EVP, Chief Scientific Officer |
1,459 | $210.39 | $306,961 | 47,262 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2023-12-29 Option Award |
2024-01-03 6:05 pm |
N/A N/A |
Mirati Therapeutics Inc. | MRTX | Christensen Jamie EVP & Chief Scientific Officer |
17,021 | $58.75 | 158,666 (Direct) |
View |
2023-08-09 Option Award |
2023-08-10 4:21 pm |
N/A N/A |
Mirati Therapeutics Inc. | MRTX | Christensen Jamie EVP & Chief Scientific Officer |
22,297 | $37 | 146,420 (Direct) |
View |
2023-01-20 Option Award |
2023-01-24 4:00 pm |
N/A 2033-01-20 |
Mirati Therapeutics Inc. | MRTX | Christensen Jamie EVP, Chief Scientific Officer |
72,320 | $0 | 170,198 (Direct) |
View |
2022-09-07 Option Award |
2022-09-09 5:35 pm |
N/A N/A |
Mirati Therapeutics Inc. | MRTX | Christensen Jamie EVP, Chief Scientific Officer |
19,149 | $0 | 106,089 (Direct) |
View |
2022-01-14 Option Award |
2022-01-18 8:33 pm |
N/A 2032-01-13 |
Mirati Therapeutics Inc. | MRTX | Christensen Jamie EVP, Chief Scientific Officer |
28,576 | $0 | 105,249 (Direct) |
View |
2021-12-16 Option Award |
2021-12-17 7:10 pm |
N/A N/A |
Mirati Therapeutics Inc. | MRTX | Christensen Jamie EVP, Chief Scientific Officer |
19,149 | $0 | 78,742 (Direct) |
View |
2021-12-03 Option Award |
2021-12-07 5:52 pm |
N/A N/A |
Mirati Therapeutics Inc. | MRTX | Christensen Jamie EVP, Chief Scientific Officer |
6,856 | $0 | 59,505 (Direct) |
View |
2021-01-15 Option Award |
2021-01-20 6:18 pm |
N/A 2031-01-14 |
Mirati Therapeutics Inc. | MRTX | Christensen Jamie EVP, Chief Scientific Officer |
18,002 | $0 | 65,264 (Direct) |
View |
2020-11-02 Exercise |
2020-11-04 5:59 pm |
N/A 2026-01-21 |
Mirati Therapeutics Inc. | MRTX | Christensen Jamie EVP, Chief Scientific Officer |
10,879 | $0 | 120,050 (Direct) |
View |
2020-11-02 Exercise |
2020-11-04 5:59 pm |
N/A N/A |
Mirati Therapeutics Inc. | MRTX | Christensen Jamie EVP, Chief Scientific Officer |
5,000 | $5.5 | 120,050 (Direct) |
View |
2020-11-02 Exercise |
2020-11-04 5:59 pm |
N/A N/A |
Mirati Therapeutics Inc. | MRTX | Christensen Jamie EVP, Chief Scientific Officer |
4,284 | $5.4 | 120,050 (Direct) |
View |
2020-11-02 Exercise |
2020-11-04 5:59 pm |
N/A N/A |
Mirati Therapeutics Inc. | MRTX | Christensen Jamie EVP, Chief Scientific Officer |
1,595 | $24.99 | 120,050 (Direct) |
View |
Ownership |
2020-09-03 06:06 am |
N/A N/A |
BCTG Acquisition Corp. | BCTG | Christensen Jamie Director |
0 | $0 | 40,600 (Direct) |
View |
2020-05-21 Option Award |
2020-05-22 5:35 pm |
N/A N/A |
Mirati Therapeutics Inc. | MRTX | Christensen Jamie EVP, Chief Scientific Officer |
5,000 | $0 | 37,842 (Direct) |
View |